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Inflammatory diseases are the result of complex and pathologically unbalanced multicel-
lular interactions. For decades, low-dose X-irradiation therapy (LD-RT) has been clinically
documented to exert an anti-inflammatory effect on benign diseases and chronic degen-
erative disorders. By contrast, experimental studies to confirm the effectiveness and to
reveal underlying cellular and molecular mechanisms are still at their early stages. Dur-
ing the last decade, however, the modulation of a multitude of immunological processes
by LD-RT has been explored in vitro and in vivo. These include leukocyte/endothelial cell
adhesion, adhesion molecule and cytokine/chemokine expression, apoptosis induction,
and mononuclear/polymorphonuclear cell metabolism and activity. Interestingly, these
mechanisms display comparable dose dependences and dose-effect relationships with
a maximum effect in the range between 0.3 and 0.7 Gy, already empirically identified to be
most effective in the clinical routine. This review summarizes data and models exploring
the mechanisms underlying the immunomodulatory properties of LD-RT that may serve as
a prerequisite for further systematic analyses to optimize low-dose irradiation procedures
in future clinical practice.
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INTRODUCTION
The relationship between ionizing radiation and an inflammatory
response displays a dichotomous character and greatly depends
on the radiation dose/quality and immune cell types investigated.
When compared to a high dose exposure with pronounced inflam-
matory promoting effects (Williams et al., 2003), low-dose irradi-
ation (single doses≤1.0 Gy) reveals anti-inflammatory properties
(Seegenschmiedt et al., 2008; Rödel et al., 2012). This implicates
the involvement of complex mechanisms differentially operating
at different dose levels (Marples et al., 2004). Although low-dose
radiation therapy (LD-RT) for the treatment of inflammatory and
degenerative diseases (Seegenschmiedt et al., 2008) is successful
in clinical use since several decades, underlying immunological
and molecular mechanisms are far from being fully explored, in
part because of their unusual discontinuous dose dependency and
non (DNA)-targeted properties. The present review focuses on
immunomodulatory properties of LD-RT to document the anti-
inflammatory efficacy with special emphasis on preclinical in vivo
models.
CLINICAL APPLICATION OF LOW-DOSE RADIATION THERAPY
The first known description of the clinical implementation of LD-
RT to treat patients with non-cancerous diseases was as early as
1898 when Sokoloff and Stenbek reported on pain relief in patients
with juvenile arthritis (Schmid-Monnard, 1898; Stenbek, 1898).
More than 100 years later, a pattern of care study performed in
Germany was published with 37,410 patients treated for inflam-
matory diseases proving LD-RT to be an accepted conservative
treatment option at least in this country (Seegenschmiedt et al.,
2004). Concepts and doses in clinical practice have been estab-
lished empirically in the early twentieth century (von Pannewitz,
1933) recommending local treatment with single doses of 0.3–
1.0 Gy in 4–5 fractions for acute and 1–3 fractions for chronic
inflammatory disorders adding to a total doses of 3–5 Gy (acute)
and 12 Gy (chronic), respectively (Seegenschmiedt et al., 2008).
Typical clinical indication comprise degenerative disorders like
rotator cuff syndrome (impingement of the shoulder joint), ten-
nis/golfer’s elbow (Epicondylopathia humeri), painful heel spur
(plantar fasciitis), exacerbated refractory, and painful osteoarthri-
tis, or hyper-proliferative syndromes like Dupytren’s disease or
the prevention of heterotopic ossification (Seegenschmiedt et al.,
2004, 2008). Concerning the most clinical relevant endpoints pain
relief, response, and analgetic effects, LD-RT is reported to result
in a 33–100%, a 47–100%, and a 12–89% efficacy, respectively
(Kutzner et al., 2003; Micke and Seegenschmiedt, 2004; Niewald
et al., 2007; Adamietz et al., 2010; Betz et al., 2010; Heyd et al.,
2010). Moreover, due to the low-doses used in actual clinical prac-
tice, radiogenic acute or chronic side effects were not observed in
the treatment of inflammatory diseases (Seegenschmiedt et al.,
2008). By contrast, LD-RT is still considered unfashionable in
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some (Anglo-American) countries due to elder reports on harm-
ful side effects and increased mortality from leukemia and anemia
(Cannon et al., 1959; Court-Braun Wm, 1965). Nevertheless, non-
steroidal or steroidal drugs used as a pharmaceutical alternative
also display numerous side effects and a considerable number of
patients does not respond to the treatment (Rainsford, 2007).
Consequently, after improving radiation protection, LD-RT is
practised on an increasing number of patients as an effective and
safe treatment routine. To underscore this, a more recent pat-
tern of care study (Mücke et al., 2010) reported on 4.500 patients
with osteoarthritis of the knee receiving LD-RT demonstrating an
increased acceptance (95% referral) of this treatment alternative
in Germany.
PRINCIPLES OF INFLAMMATION
Inflammation comprises a complex and basic immunological
response to harmful stimuli, such as pathogens, damaged cells,
or irritants to remove the stimuli and to initiate a healing process.
Moreover, inflammation is a stereotyped response, and therefore
is considered to be a mechanism of innate immunity, in contrast to
a pathogen specific adaptive immunity (Murphy, 2011). A cascade
of biochemical events propagates and matures the inflammatory
response, involving the local vascular system. A pivotal molecu-
lar mechanism in the regulation of the inflammatory response
is the secretion of regulatory cytokines. Whereas interleukin-1
(IL-1) or tumor necrosis factor-α (TNF-α) activate cellular com-
ponents in a pro-inflammatory manner, anti-inflammatory pep-
tides like the isoforms of transforming growth factor β (TGF-β1–3)
or IL-10 down regulate and thus limit the inflammatory cascade
(Mosmann, 1994).
An early event in the inflammatory cascade is the recruitment of
leukocytes from peripheral blood by activation of local endothelial
cells (ECs) with pro-inflammatory mediators mainly produced by
macrophages and dendritic cells (DCs) at the site of the damaged
tissue (Speyer and Ward, 2011). The subsequent effector phase of
inflammation is characterized by the accumulation of monocytes
and their differentiation into DCs or inflammatory macrophages
(Adams, 1989). These cells support the local inflammatory process
by a plethora of functions like phagocytosis, cytotoxicity, antigen
presentation, secretion of cytokines, and the production of nitric
oxide (NO), or reactive oxygen intermediates (Ding et al., 1988).
Inflammation can be further classified as either acute or chronic
(prolonged), characterized by a progressive shift in the type of
cells present at the site of inflammation and by simultaneous
destruction of the tissue from the inflammatory process.
MODULATORY PROPERTIES ON ENDOTHELIAL CELLS OF
LOW-DOSE IRRADIATION
As reported before, EC play a crucial role in the regulation of
the local inflammatory process both by their ability to recruit
leukocytes from peripheral blood and to express a variety of
cytokines/chemokines and growth factors (Speyer and Ward,
2011). As a consequence, the effect of low-dose irradiation on
the adhesion process was analyzed in in vitro assays using human
(EA.Hy926) or murine (mlEND1) EC and peripheral blood
mononuclear cells (PBMC). LD-RT prior to the stimulation by
TNF-α resulted in a hampered adhesion of PBMC to 43–50% of
the control level at 4 and 24 h but elevated values at 12 h after
irradiation with a single dose of 0.3–0.6 Gy (Kern et al., 2000a;
Hildebrandt et al., 2002; Rödel et al., 2002). This characteristic
coincides with a biphasic kinetic and elevated expression of the
anti-inflammatory cytokine TGF-β1 both on the levels of mRNA
and protein in the same dose range. Moreover, abrogation of
TGF-β1 by neutralizing antibodies restored adhesion of PBMC
to irradiated EC (Rödel et al., 2004b), indicating the cytokine to
be a key player in the modulation of adhesion following low-dose
exposure. A hampered adhesion is further supported by a lowered
expression of the adhesion molecule E-selectin on stimulated EC
with a local minimum following a 0.3–0.5 Gy exposure. This indi-
cates that the modulation of E-selectin may further contribute to
the anti-inflammatory properties of LD-RT (Hildebrandt et al.,
2002; Rödel et al., 2002).
MODULATORY PROPERTIES ON LEUKOCYTES OF LOW-DOSE
IRRADIATION
The major cellular elements of the immune system comprise dif-
ferent lineages of lymphocytes (B and T cells) as members of an
antigen-specific effector response, as well as polymorphonuclear
(PMN) and mononuclear leukocytes (PBMC) as components of
the innate immune system (Kobayashi et al., 2005). As outlined
below, these immune cells are modulated by distinct low-doses of
X-ray.
Apoptosis is a physiological endogenous cellular suicide pro-
gram mediated by a variety of endogenous and exogenous stimuli
including ionizing irradiation (Hengartner, 2000). Beside its cen-
tral role in cellular homeostasis, apoptosis significantly impacts
on immune regulation and radiation response. In line with that,
cells undergoing apoptosis contribute to the modulation of acti-
vated mononuclear cell activity in a paradox manner by reducing
the secretion of pro-inflammatory cytokines like TNF-α or IL-
1. In addition, secretion of the anti-inflammatory peptide IL-10
is increased indicating an immune-suppressive potential of apop-
totic cells (Voll et al., 1997). In 1999, Kern et al. (1999) were the first
to report on a dose-dependent discontinuous increase of apoptosis
in PBMC with a plateau or peak between a 0.3 and 0.7 Gy exposure.
Additionally, the coincidence of a reduced PBMC/EC adhesion (as
reported before) and induction of apoptotic cell death in PBMC
prompted the group to investigate a putative link to the expres-
sion of adhesion molecules on the surface of the PBMC. They
described a time-dependent proteolytic shedding of L-selectin that
was associated with their early apoptotic phenotype (Kern et al.,
2000b). More recently, a comparable performance of apoptosis
induction was reported for PMN irradiated 2 h before stimula-
tion with phorbol myristate acetate (PMA). Applying subG1 DNA
content analyses, a discontinuous appearance of cell death was
observed, showing a relative maximum at 0.3 Gy and a minimum
at 0.5 Gy, respectively (Gaipl et al., 2009). Notably, the discontin-
uous course of apoptosis parallels a diminished protein level of
mitogen activated protein (MAP) kinases and protein kinase B (or
AKT), reported to be involved in the regulation of proliferation,
transcription, and apoptosis (Yang et al., 2004).
Neutrophilic PMN accumulation has been implicated in the
pathology of acute and chronic inflammatory diseases, such as
rheumatoid arthritis (Witko-Sarsat et al., 2000) in part by the
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secretion of chemotactic cytokines with the potential to amplify
leukocyte infiltration (Scapini et al., 2000). Thus, the impact of LD-
RT on chemokine secretion in PMN was analyzed. In comparison
to CXCL8 and CCL18, CCL20 chemokine was shown to be exclu-
sively induced in a TNF-α dependent manner by a cell–cell contact
between PMN and EA.hy926 EC. Furthermore, irradiation with
doses between 0.5 and 1.0 Gy resulted in a discontinuous reduction
of CCL20 secretion that parallels a hampered PMN adhesion to EC
with a pronounced effect at a 0.7 Gy exposure (Rödel et al., 2008).
Very recently, Bauer et al. (2011) reported that monocytes are
severely impaired in base and DNA double-strand break repair that
renders them highly vulnerable to ROS and irradiation induced
cell death by apoptosis. Thus, it is tempting to assume that a
selective killing of monocytes at doses below 1 Gy may cause a
depletion of macrophages and DCs that may further contribute to
the anti-inflammatory effects of LD-RT.
MODULATORY PROPERTIES ON MACROPHAGES AND DCS
OF LOW-DOSE IRRADIATION
Monocytes, unlike PMN, differentiate into tissue resident DCs
or macrophages (Adams, 1989). Due to their central role in the
initiation and the resolution of inflammatory processes, these
cells are considered as key players in the regulation of inflam-
mation (Valledor et al., 2010). Macrophages for example support
a local inflammatory process by a variety of functions including
phagocytosis, antigen presentation, secretion of cytokines, and the
expression of enzymes like inducible nitric oxide synthase (iNOS;
Fujiwara and Kobayashi, 2005). The latter enzyme processes the
synthesis of nitric oxide (NO) that in turn increases vascular
permeability and is involved in inflammatory pain (Holthusen,
1997; Abramson et al., 2001). In that context, low-dose radiation
(≤1.0 Gy), if applied before stimulation with lipopolysaccharide
(LPS) and interferon-γ (IFN-γ) of murine RAW 264.7 cells (a
mouse leukemic monocyte macrophage line) decreases iNOS pro-
tein and NO production without affecting iNOS mRNA expression
(Hildebrandt et al., 1998). This may indicate a translational or
post-translational regulation of the enzyme that is linked, at least
in part, to the analgetic properties of LD-RT.
Tsukimoto et al. further examined signal transduction path-
ways in RAW264.7 macrophage cells following γ-irradiation
(137Cs source) with doses of 0.5–1.0 Gy. Dephosphorylation of
both extracellular-signal-regulated kinases 1/2 (ERK1/2) and p38
mitogen activated protein kinase (MAPK) was observed at 15 min
after irradiation which was concomitant with a significant increase
in the expression of the MAPK phosphatase-1 (MKP-1; Tsuki-
moto et al., 2009). Since activated p38 MAPK mediates pro-
inflammatory cytokine expression, they further assayed the effect
of low-dose radiation on TNF-α, showing that production of the
cytokine induced by LPS was significantly suppressed in 0.5 Gy
irradiated macrophages.
A further essential inflammatory cytokine is the IL-1 family
member IL-1β, which shows numerous activities in the inflamma-
tory process (Dinarello, 2011). Using RAW264.7 macrophages, a
non-linearity in IL-1β production was observed after high-linear
energy transfer (LET) carbon ion radiation (Conrad et al., 2009).
Notably, as compared to other inflammatory cytokines, expression
of IL-1β is tightly regulated by a three step process and requires
two distinct stimuli (Tschopp et al., 2003). In more recent studies
using human THP-1 derived macrophages which were stimulated
by LPS and MSU (mono sodium urate crystals) a significantly
decreased IL-1β secretion at doses of 0.5 and 0.7 Gy was con-
firmed by Lödermann et al. (2012). In their experiments, the
IL-1β machinery (also called the NALP3 inflammasome) was not
affected by the doses used, but a hampered secretion of the IL-1β
correlates with a reduction in nuclear translocation of the tran-
scription factor nuclear factor κB (NF-κB) subunit RelA (p65) in
line with a decreased protein amount of upstream (p38 MAPK)
and downstream molecules (AKT). Thus it is tempting to con-
clude, that the discontinuous regulation of IL-1β following LD-RT
may occur in a NF-κB dependent manner.
Furthermore,activated macrophages are a major source of reac-
tive oxygen species (ROS) when they mount an oxidative burst to
destroy pathogens. Accordingly, the impact of low-dose irradia-
tion on oxidative burst activity and superoxide production was
investigated in RAW 264.7 macrophages after stimulation with
TNF-α/IFNγ, PMA, or the yeast product zymosan. Low X-ray
doses between 0.3 and 0.6 Gy significantly reduced the oxidative
burst in these activated macrophages, whereas higher doses had
little effect. This indicates that a diminished release of ROS may
contribute to the local therapeutic effect of LD-RT (Schaue et al.,
2002).
Finally, Jahns et al. recently analyzed the effect of LD-RT on
the maturation, cytokine release, and T-Lymphocyte activation of
human DCs. They indicated that irradiation of DC-precursors
in vitro does not influence surface marker (CD80, CD83, CD86)
expression or cytokine profile of immature DCs nor of mature
DCs stimulated by LPS, neither did it influence the capacity of the
DCs to stimulate T-cell proliferation (Jahns et al., 2011).
MODULATION OF TRANSCRIPTION FACTOR ACTIVITY BY
LOW-DOSE IRRADIATION
As there is enormous evidence for the involvement of cellular
transcription factors including TP53, activating protein 1 (AP-1),
and NF-κB in both, cellular radiation response and inflammation
(Habraken and Piette, 2006), they may also represent a crucial
link between low-dose radiation and their immune modulatory
properties. The family of NF-κB transcription factors comprises a
heterogeneous group of homo- or heterodimeric members of the
Rel family including p50, p52, p65/RelA, c-Rel, and RelB (Baeuerle
and Baltimore, 1996; Oeckinghaus et al., 2011). NF-κB is located
in the cytoplasm in an inactive form by binding to inhibitor mol-
ecules of the IκB family (IκBα, IκBβ, IκBγ/NEMO, IκBε, p100,
and p105; Huxford and Ghosh, 2009). Upon dissociation of the
inhibitors, NF-κB dimers translocate into the nucleus and bind
specific sequence elements in the enhancer/promoter regions of
a variety of effector genes. These include factors implicated in
DNA damage repair, the execution, or inhibition of cell death
by apoptosis (Oeckinghaus et al., 2011) and cytokines (e.g., IL-1,
TNF-α), adhesion molecules (e.g., E-selectin), and enzymes (e.g.,
iNOS) essential in the regulation of the immune system (Kracht
and Saklatvala, 2002). In the field of low-dose irradiation, Prasad
et al. (1994) were the first to report on an activation of NF-κB in
a discontinuous manner with peak activities at 8 and 36 h after
irradiation analyzed in 244B lymphoblastoid and B16 melanoma
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cells. In accordance to these findings, a comparable time depen-
dence of DNA binding and transcriptional activity with a first peak
at 4 h and a second peak at 24–30 h was confirmed in stimulated
human EA.Hy926 EC (Rödel et al., 2004a). Based on these initial
observations, factors engaged in the pathway(s) of NF-κB activa-
tion in stimulated EA.Hy926 EC were investigated. Among these
regulatory proteins, X chromosome-linked inhibitor of apoptosis
protein (XIAP) that enhances RelA/p65 nuclear translocation and
promotes the degradation of IkB (Hofer-Warbinek et al., 2000;
Jin et al., 2009) was investigated in more detail. Following irra-
diation, a discontinuous profile of XIAP-expression was observed
with a relative maximum at 0.5 and 3.0 Gy which parallels a dis-
continuity in NF-κB induction. Furthermore, RNA-interference
(siRNA) derived knockdown of XIAP resulted in a hampered
NF-κB transcriptional activity, indicating a regulatory interrela-
tionship between these factors (Rödel et al., 2010). These findings
are in agreement with the observation that XIAP interacts with
MAP Kinase Kinase 2 (MEKK2). The latter has previously been
shown to be associated with a second wave NF-κB activation
and the propagation of inflammatory processes (Winsauer et al.,
2008). Moreover, a functional consequence of XIAP-expression
and altered NF-κB activity on the adhesion process was obvi-
ous since XIAP attenuation showed an abrogation of the reduced
PBMC binding normally observed following a 0.5 Gy exposure.
This effect is, at least in part, driven by a reduced secretion of the
cytokine TGF-β1, a key player in the anti-inflammatory effects of
low-dose irradiation (Rödel et al., 2007).
Members of the c-Fos and c-Jun protein family that collectively
form the homo- or heterodimeric AP-1 complex (Criswell et al.,
2003), are considered to be involved in the transcription of a vari-
ety of immune effector molecules, including TGF-β1. By applying
electrophoretic mobility shift assays (EMSA) and luciferase based
transcriptional activity assays, a biphasic induction of AP-1 was
detected in EA.Hy 926 EC (Rödel et al., 2009) that may further
contribute to the immunomodulatory properties of LD-RT.
MECHANISMS UNDERLYING A DISCONTINUOUS
CHARACTERISTIC OF LOW-DOSE IRRADIATION EFFECTS
The classical paradigm of radiation biology is based on the con-
cept, that deposition of energy to the nucleus and the resulting
DNA damage is responsible for the biological consequences of
radiation exposure. By contrast, based on recent findings, there is
growing evidence for non-(DNA) targeted effects that challenged
this classical concept. Among these findings bystander or distant
out of field (abscopal) mechanisms, as well as adaptive responses
have been reported (Mothersill and Seymour, 2006; Hildebrandt,
2010). Notably, these novel concepts also take into consideration
a complex intercellular communication and describe radiation
responses on a tissue level (Barcellos-Hoff, 2005). The molecu-
lar mechanisms responsible for the discontinuous dose response
characteristics, a common hallmark of these non-targeted effects,
remain elusive at present and most likely originate from an over-
lap of several processes that may be initiated at various thresholds
and operate in a staggered manner. There may also be paral-
lels to the phenomenon of low-dose hyper-radiosensitivity and
induced radioresistance, which have been reported for cellular
survival at doses below 0.3 Gy and in the dose range of 0.3–
0.6 Gy (Joiner et al., 2001; Marples and Collis, 2008). The current
hypothesis on the regulation of this behavior is that the HRS
region (<0.3 Gy) reflects an area of increased induction of apopto-
sis in cells that failed to undergo an ataxia telangiectasia-mutated
(ATM)-dependent G2-phase cell cycle arrest. By contrast, a tran-
sition to induced radioresistance originates from a shift toward
a G2-checkpoint induction, giving time for repair of DNA dam-
age, and to increase cell survival. Corresponding to this, DNA
double-strand breaks induced after very low-dose irradiation do
not seem to be repaired, and cells containing residual dam-
age were removed by a TP53-dependent apoptosis (Rothkamm
and Löbrich, 2003). Interestingly, two seminal molecular studies
(Xu et al., 2002; Bakkenist and Kastan, 2003) have shown dis-
continuous responses over the 0.1–1.0 Gy dose range, the most
important being the activation and (auto)phosphorylation of the
DNA damage sensor ATM. Once activated, ATM is implicated in
several signaling cascades and is essential for the regulation of
a cell cycle arrest, DNA damage repair, and acts as an inducer
of the ATM–IκK–NF-κB signaling pathway (Hacker and Karin,
2006).
Based on these findings, it is reasonable to assume that beside
DNA (repair)-mediated mechanisms, a non-linear dose-effect
relationship may be associated with a differential protein expres-
sion. In line with that, Pluder and colleagues recently reported that
exposure to Co60 γ-rays of EA.hy926 EC resulted in rapid change
in the cytoplasmic proteome. The group identified 15 signifi-
cantly differentially expressed proteins of which 10 were up- and
5 down-regulated. Pathways influenced by the factors include the
RhoA pathway, fatty acid metabolism, and cellular stress response
(Pluder et al., 2011).
ANTI-INFLAMMATORY PROPERTIES IN PRECLINICAL
MODELS OF LD-RT
Beside an increasing knowledge concerning underlying mecha-
nisms, in vivo models of experimentally induced arthritis (Gilroy
et al., 1998) have been established to investigate a clinical anti-
inflammatory efficacy of LD-RT. In 1933 von Pannewitz (1933)
reported on a first series of animal studies, when rabbits with
electro-coagulation of the knee joint cartilage or by mechanical
bone destruction were treated with 1.0 Gy single dose irradia-
tion. This treatment does not show a benefit on the degenerative
changes, however, an improvement of the symptoms joint swelling
(an indicator of reduced inflammation) and pain was observed. In
subsequent years a variety of inducible models have been estab-
lished to more closely mimic the situation in joints of patients
suffering from rheumatoid arthritis (Smolen and Steiner, 2003).
Experimental induction of arthritis in rodents treated either with
zymosan (a yeast product) or inactivated mycobacterium tubercu-
losis (mtb) results in a fast (five days from injection) joint swelling
associated with cartilage destruction and bone loss (Asquith et al.,
2009). Using an intra-articular injection of papain, inactivated
mtb or zymosan, Budras et al., Trott et al., and Fischer et al.
induced an acute arthritis in rabbit knees. In their experiments
five weekly fractions of 1.5 or 1.0 Gy significantly diminished the
inflammatory proliferation of the synovial cover cells, the synthesis
of synovial fluid, and thus swelling of the joint (Budras et al., 1986;
Trott et al., 1995; Fischer et al., 1998). Although partially not reach-
ing a level of significance, morphometric data further revealed a
decreased number of the synovial cell layers and thus thickness of
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the synovial membrane and a lowered distance between capillaries
and synovial membranes following irradiation.
The effects of LD-RT on morphological progression of adjuvant
induced arthritis in rats were further investigated by Hildebrandt
et al. In their analysis, local irradiation of the arthritic joints
reduced clinical symptoms, if given at days 15–19 after induction of
arthritis by intradermal injection of mtb. Histopathological analy-
sis performed at days 21 and 30 revealed a significant reduction of
cartilage and bone destruction with minimal effect on the number
of inflammatory cells in the periarticular tissue (Hildebrandt et al.,
2000). In addition, the histologically observed prevention of dis-
ease progression appears to be related to a modulation of the iNOS
activity with a reduction of the histochemical iNOS score and
increase of heme oxygenase-1 (HO-1) expression (Hildebrandt
et al., 2003).
Most of the analyses as reported before, however, used single
fractions that exceed a dose of 1.0 Gy. In order to explore the low-
est effective dose, the optimal time of treatment and the most
favorable schedule, the effect of different fractionation schemes
was analyzed by Liebmann et al. The most pronounced treatment
effect was observed after two daily fractionated series of 5× 0.5 Gy
with an early treatment onset (days 10–14) and repetition after an
interval of 8 days (days 22–26; Liebmann et al., 2004).
Relevantly, a variety of mechanisms, recognized in in vitro
investigations to contribute to the immunomodulatory proper-
ties of LD-RT, were confirmed in the in vivo situation. Using an
air pouch model in NMRI mice, the expression of TNF-α, IL-
1β, and the proteins iNOS, HO-1, cyclooxygenase-2 (Cox2), and
heat shock protein 70 (Hsp70) were investigated. Whereas the
amount of exudates and number of inflammatory cells mainly
remained unaffected, iNOS expression was decreased by irradi-
ation concomitant with an increased expression of Hsp70 and
HO-1 (Schaue et al., 2005). In addition, as binding of lymphocytes
to blood vessel EC is crucial to drive an inflammatory process, the
impact of LD-RT on adhesion and extravasation was analyzed by
intra-vital microscopy in mice stimulated with LPS. In accordance
to the in vitro findings, leukocyte adhesion in intestinal venules
was diminished after irradiation with 0.1, 0.3, and 0.6 Gy, respec-
tively (Arenas et al., 2006). This mechanistically correlated with
increased levels of TGF-β1 in the serum of the mice, and partially
could be restored by neutralization of the cytokine.
In a model of collagen inducible arthritis (CIA), DBA/1J mice
were irradiated once before induction and on consecutive 4 weeks
with a single dose of 0.5 Gy. The authors described a significant
improvement of the clinical symptoms associated with a reduced
amount of antitype II collagen antibodies and reduced values of
inflammatory cytokines TNF-α, IFN-γ, and IL-6 in the serum of
treated mice (Nakatsukasa et al., 2008). In proceeding analyses,
the group further reported on a significant increased propor-
tion of CD4(+)CD25(+)FoxP3(+) regulatory (Treg) cells in the
spleen of irradiated mice at 4, 6, and 8 weeks after immunization
with collagen and a hampered secretion of inflammatory IL-17
and IL-6 (Nakatsukasa et al., 2010). Tregs in turn are reported to
act as suppressors of osteoclast cell activity, which drive arthritis
and bone loss and therefore may contribute to the reduction of
the clinical symptoms in mice treated with low-dose irradiation
(Zaiss et al., 2010). In accordance to these observations, Weng et al.
(2010) reported that a therapeutic effect of low-dose irradiation
was associated with an increment in the proportion of Treg cells
despite the overall reduction in lymphocyte count. By contrast,
depletion of CD25 or folate receptor (FR)4(+) cells with specific
antibodies before the treatment abolished the beneficial effects of
irradiation confirming a fundamental role of Treg.
The models mentioned beforehand, however, suffer from the
fact of an artificial induction of pathologic conditions in for-
mer healthy animals, that does in detail not reflect the situation
in arthritic patients which are suffering from the disease since
years and display an autoimmune status (Imboden, 2009). To
overcome these limitations, Frey et al. (2009) were the first to ana-
lyze effects of low-dose irradiation in human TNF-α transgenic
(hTNFtg) mice (Frey et al., 2009). These animals overexpress the
cytokine TNF-α during their whole lifetime and develop a geneti-
cally determined polyarthritis (PA), with an onset after 3–6 weeks
of age (beginning PA). The disease pattern in animals shows sim-
ilarity to a human rheumatoid arthritis such as joint swelling
and deformation, synovial inflammation, cartilage damage, and
bone erosion, and is fully blown at an age of 9–12 weeks (Kef-
fer et al., 1991). Irradiation of these mice with five times 0.5 Gy
at a beginning (4–6 weeks) PA demonstrates significantly tempo-
ral improved clinical symptoms like a reduced paw swelling and
increased grip strength. Those effects are less pronounced at later
stages of the disease (9–12 weeks, fully established PA; Frey et al.,
2009).
More insight on the impact of low-dose irradiation further
arises from experiments on genetically determined MRL-lpr/lpr
mouse autoimmune diseases. These animals are characterized by
a deletion in the TNF receptor superfamily member six (FAS)
gene resulting in an impaired apoptosis of autoreactive lympho-
cytes and aberrant T cell proliferation, concomitant with massive
autoantibody production, immune complex glomerulonephritis,
and arthritis. If irradiated with a daily single dose of 0.5 Gy for
4 weeks to a total dose of 10 Gy the mass of the spleen of the
MRL-lpr/lpr mice was significantly reduced in line with a dras-
tically reduced amount of CD3(+)CD4(−)CD8(−)B220(+) T
cells, which drive the splenomegaly (Tago et al., 2008). In an
additional model of experimental autoimmune encephalomyelitis
(EAE) animals were irradiated with a total dose of 5.5 Gy, sub-
divided in 0.5 Gy fractions over 5 weeks (one fraction before
induction and four fractions once a week for 4 weeks) resulting
in a reduced EAE incidence along with a significant improved
clinical score and delayed onset of pathological changes (Tsuki-
moto et al., 2008). These effects may arise from a hampered ability
of spleenocytes to produce the pro-inflammatory cytokines IL-6,
and IL-17. Furthermore, irradiated mice spleenocytes exhibited a
reduced IFN-γ secretion and shifted the Th1/Th2 balance to an
anti-inflammatory phenotype.
In summary, in vivo data and models clearly confirmed anti-
inflammatory effects and have proven true a variety of immune
modulatory effects of low-dose irradiation as summarized in
Table 1. They may display suitable platforms for an intensified
research of the underlying mechanisms and on options to improve
the clinical efficacy of LD-RT.
CONCLUSION
Considerable progress has recently been achieved in the under-
standing of cellular targets and molecular mechanisms involved
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FIGURE 1 | Actual model on the modulation of inflammatory cell activity
and factors involved in the anti-inflammatory effect of LD-RT (<1 Gy).
Irradiation resulted in a hampered adhesion of peripheral blood mononuclear
cells (PBMC) to the endothelium, due to the secretion of the
anti-inflammatory cytokine transforming growth factor β1 (TGF-β1), a
decreased expression of E-selectin on the surfaces of endothelial cells, a local
increase of apoptosis, and the proteolytic shedding of L-selectin from PBMC.
In stimulated macrophages a diminished activity of the inducible nitric oxide
synthase (iNOS) in line with reduced levels of nitric oxide (NO), a lowered
production of reactive oxygen species (ROS), and a diminished secretion of
interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) may contribute to
local anti-inflammatory effects. Moreover, polymorphonuclear cells (PMN)
respond to low-dose exposure with a locally increased rate of apoptosis, a
hampered secretion of CCL20 chemokine and alterations in signal
transduction pathways p38 mitogen activated protein kinase (MAPK) and
protein kinase B (AKT).
in the immune modulatory properties of low-dose irradiation
as depicted in Figure 1. However, as (chronic) inflam-
matory and degenerative diseases are based upon complex
(patho)physiological networks, a variety of yet unresolved ques-
tions exists. Thus, intensive translational and clinical research
efforts as well as the development of further basic models are
seriously needed to recognize additional contributing factors and
mechanisms. Moreover, on-going efforts should also focus on
a putative relationship to tumor immune biology to optimize
clinical use of radiation therapy of both benign and malignant
diseases.
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